Liver Cancer News
2026
January 2026
Restricting Dietary Protein Could Prevent Liver Cancer Development in At-Risk Patients
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
Scientists Discover Potential New Cancer Treatment
HCC: LLM Advice and Treatment Concordance
AI Treatment Suggestions for Liver Cancer More Accurate at Early Stages
Atezolizumab Combo May Be Superior to TACE for Certain Liver Cancers
A Natural “Safety Switch” Protects the Liver as it Heals from Injury, Study Finds
Scientists Warn Of Hidden Cancer Risk In Popular Fatty Liver Treatment Strategy
Adjuvant Pembrolizumab Fails in Phase 3 Liver Cancer Trial
Atezolizumab Plus Bevacizumab Shows Potential Advantage Over TACE in Intermediate-Stage HCC
Your Liver May Already Be Changing Because Of What You Eat Every Day, Scientists Warn
Breaking Down Key Misconceptions in Hepatocellular Carcinoma Care
Ablation Success Rate for Liver Cancer. What Patients Need to Know in 2026
For past liver cancer news, please visit our Liver Cancer News Archives.